Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients With Moderate or Severe Haemophilia A in India

NCT03449342 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT03449342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03449342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients With Moderate or Severe Haemophilia A in India
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2018
Completion date
April 22, 2019
Enrollment
60 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia a